Otofarma SpA (MIL:OTO) Retained Earnings: €2.03 Mil (As of Dec. 2024)


MIL:OTO Otofarma SpA MIL:OTO
16 GF Score
Price €2.70
! 1 Warning Sign
View Full Analysis

What is Otofarma SpA Retained Earnings?

Otofarma SpA MIL:OTO -2.17% 16 Retained Earnings is €2.03 Mil as of Dec. 2024. GuruFocus rates MIL:OTO with a GF Score™ of 16/100. The stock has 1 warning sign investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Otofarma SpA's retained earnings for the quarter that ended in Dec. 2024 was €2.03 Mil.

Otofarma SpA's quarterly retained earnings increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.62 Mil) and increased from Dec. 2023 (€0.62 Mil) to Dec. 2024 (€2.03 Mil).

Otofarma SpA's annual retained earnings increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.62 Mil) and increased from Dec. 2023 (€0.62 Mil) to Dec. 2024 (€2.03 Mil).


Otofarma SpA  (MIL:OTO) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Otofarma SpA Retained Earnings Historical Data

* Premium members only.

The historical data trend for Otofarma SpA's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Otofarma SpA Retained Earnings Chart

Otofarma SpA Annual Data
Trend Dec23 Dec24
Retained Earnings
0.62 2.03

Otofarma SpA Semi-Annual Data
Dec23 Dec24
Retained Earnings 0.62 2.03
MIL:OTO
16GF Score
Otofarma SpA MIL:OTO
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Otofarma SpA Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of €2.03 Mil mean?
Otofarma SpA (MIL:OTO) has a Retained Earnings of €2.03 Mil as of Dec. 2024. Retained earnings is the amount of net income not issued to shareholders. View historical data on Otofarma SpA and its competitors.
Is Otofarma SpA's Retained Earnings too high?
Otofarma SpA's current Retained Earnings is €2.03 Mil. Overall, Otofarma SpA has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Otofarma SpA's Retained Earnings compare to ABT and SYK?
Otofarma SpA's Retained Earnings of €2.03 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Devices & Instruments company?
A good Retained Earnings depends on the Medical Devices & Instruments industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Otofarma SpA and its competitors. Otofarma SpA's current Retained Earnings is €2.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Otofarma SpA stock overvalued right now?
Otofarma SpA (MIL:OTO) has a current Retained Earnings of €2.03 Mil. The current Retained Earnings is €2.03 Mil. Otofarma SpA's overall GF Score™ is 16/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Otofarma SpA (MIL:OTO), the current Retained Earnings is €2.03 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Otofarma SpA Business Description

Address Ripuaria Way, 50k, Marina di Varcaturo, Naples, ITA, 80014
Otofarma SpA is engaged in the construction and production of hearing aids, is constantly growing in the audiological field to provide adequate responses to every type of hearing aid need to its customers who require the possible personalized application of custom-made hearing aids. It provides otoacoustic medical devices and TELEMEDICINE services exclusively in affiliated pharmacies, possessing a portfolio of Instrumental IT patents.
16GF Score

Get the complete analysis for MIL:OTO

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.70
Price